17th World ADC London Summit
March 8 - 11, 2027 - GBHanson Wade Group
info@hansonwade.com
Phone:+1 617 455 4188
As ADCs continue to redefine the standard of care in oncology, breakthrough clinical readouts, expanding approvals in earlier treatment settings, and a wave of landmark dealmaking have cemented ADCs as one of biopharma's most sought-after areas of investment. From Novartis' billion-dollar technology partnership with Myricx Bio to Gilead's acquisition of Tubulis, the industry's leading players are racing to secure differentiated linker-payload technologies, unlock novel targets, and develop the next generation of transformative ADC therapies for patients with hard-to-treat cancers. Returning as Europe's largest and longest-standing annual meeting for the ADC community, the 17th World ADC London returns in March as the definitive week to benchmark against industry leaders, validate internal strategies, forge strategic partnerships, and shape the future of ADC development. Bringing together 700+ senior leaders from biopharma, biotech, academia, clinical research, investment, and solution providers, this is where the brightest minds and most innovative companies converge to accelerate progress across the field. Featuring five streams of end-to-end content spanning discovery, preclinical and translational development, clinical lessons, process and analytical development, and manufacturing and supply chain, the 2027 agenda is curated to spotlight next-generation conjugate design, strategies to overcome resistance mechanisms, and the latest innovations accelerating ADCs towards clinical validation and earlier lines of treatment. As investment accelerates and competition for differentiated ADC technologies intensifies, this is the must-attend forum for the European and global ADC community to uncover breakthrough insights, benchmark against industry leaders, validate internal strategies, forge strategic partnerships, and gain the market intelligence needed to shape the next wave of ADC innovation. Whether you're racing to develop the next blockbuster beyond Enhertu, overcome resistance mechanisms, unlock novel targets, or bring differentiated ADCs to patients faster, World ADC London is your annual opportunity to stay ahead of the trends, technologies, and partnerships defining the future of the field. Time: 8:00 AM - 4:00 PM